Gartisertib-d8
Gartisertib-d8 (VX-803-d8) is the deuterium labeled Gartisertib (HY-136270). Gartisertib (VX-803) is an ATP-competitive, orally active, and selective ATR inhibitor, with a Ki of <150 pM. Gartisertib potently inhibits ATR-driven phosphorylated checkpoint kinase-1 (Chk1) phosphorylation with an IC50 of 8 nM. Antitumor activity.
For research use only. We do not sell to patients.
- CAS No.: 1792214-00-6
- Formula: C25H21D8F2N9O3
- Molecular Weight:549.60
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS No. 1792214-00-6
-
Unlabeled Cas 1613191-99-3
-
Molecular Weight 549.60
-
Formula C25H21D8F2N9O3
-
SMILES
O=C(C1=C2N=CC(F)=CN2N=C1N)NC3=C(N4CCC(C(N5C([2H])([2H])C([2H])([2H])N(C6COC6)C([2H])([2H])C5([2H])[2H])=O)CC4)C(F)=CN=C3
-
Synonyms
VX-803-d8; M4344-d8; ATR inhibitor 2-d8
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Powered by Bioz